The Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

A nasal vaccine for COVID-19 – based on technology developed at ... after an investigational new drug application from Ocugen, Inc. was approved by the Food and Drug Administration (FDA). Ocugen, a ...

With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, ...

Ocugen, Inc. announced that the FDA has approved its Investigational New Drug application for OCU500, a mucosal vaccine for COVID-19, which will be delivered via inhalation and as a nasal spray.

Robert F. Kennedy Jr. made claims during his Senate confirmation hearing on issues including vaccines, pesticides and Lyme ...

A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

During his Senate confirmation hearing, Kennedy claimed he is not against vaccination, contrary to decades of public comments ...

When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...